NDC 68382-0754-67: temozolomide 140 mg Capsule, Bottle of 14
This is a package of 14 capsules of temozolomide 140 mg Capsule from Zydus Pharmaceuticals USA Inc., no longer marketed, no longer in the FDA NDC Directory. It is the main listing for this product, which comes in 2 package sizes.
NDC database record
One package, one record: these facts belong to NDC 68382-754-67 alone.
- Record
- FDA NDC Directory package listing · Human prescription drug
- Code segments
- 68382 labeler · 754 product · 67 package
- Billing quantity
- 14 EA per package
- Barcode (UPC-A, from the NDC)
- 3 6838275467 7
- FDA record last changed
- Mar 13, 2024
Other active recalls for Temozolomide (different manufacturers) — 1 · tap to view
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 062535
- GCN: 98310
- HICL (First Databank): 020355
- AHFS class code: 10:00.00.00
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
Temozolomide is used to treat certain types of brain tumors. Temozolomide is in a class of medications called alkylating agents. It works by slowing or stopping the growth of cancer cells in your body.
Read the full MedlinePlus article ↗- Temozolomide is a chemotherapy used to treat aggressive brain tumors — specifically glioblastoma (a fast-growing brain tumor) and anaplastic astrocytoma. It works by getting into c...
- What exactly is temozolomide treating, and why do I need it?
- Yes, it does matter. Swallow the capsules whole with a full glass of water — never open, crush, or chew them. Try to avoid taking them right after a high-fat meal, because fat can...
- How should I take the capsules — does it matter when I take them or whether I eat first?
Patient education
Drug interactions
Supplement & herbal interactions
Some supplements/herbs that may interact with Temozolomide — tap one for details:
Temozolomide may be associated with lower levels of 1 nutrient — worth a chat with your pharmacist, not a cause for alarm.
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
| Medicare Part B allowsASP · NONE | No ASP payment limit on file for NONE this quarter. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Billing & reimbursement
Where does this data come from?
- CMS ASP NDC-HCPCS crosswalk · refreshed Nov 22, 2026
- DMEPDAC NDC-HCPCS crosswalk
- openFDA NSDE billing units · refreshed Nov 7, 2026
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 68382-0754-67 You're viewing this Main listing | 14 CAPSULE in 1 BOTTLE | 2017-10-26 | — | Discontinued by firm |
| 68382-0754-96 68382-754-96 | 5 CAPSULE in 1 BOTTLE | 2017-10-26 | — | Discontinued by firm |
You're viewing the largest of 2 pack sizes for this product.
Pack size FAQ
What quantity is in this package?
How does this package differ from NDC 68382-0754-96?
What NDC number is used to bill for this package of temozolomide 140 mg Capsule?
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| temozolomide 140 mg 75834-0144-05 | Nivagen | 5 capsules | $8.305 | — | FDA listed | — |
| Temozolomide 140 mg 47335-0929-21 | Sun | 14 capsules | $10.725 | AB | FDA listed | — |
| Temozolomide 140 mg 16729-0129-53 | Accord | 5 capsules | $11.461 | AB | FDA listed | — |
| Temozolomide 140 mg 31722-0414-14 | Camber | 14 capsules | $11.461 | AB | FDA listed | — |
| Temozolomide 140 mg 65162-0804-14 | Amneal | 14 capsules | $11.461 | AB | FDA listed | — |
| Temozolomide 140 mg 67877-0540-07 | Ascend | 5 capsules | $11.461 | AB | FDA listed | — |
| Temozolomide 140 mg 73043-0014-05 | Devatis, | 5 capsules | $11.461 | AB | FDA listed | — |
| Temodar 140 mg 00085-1425-03 | Merck | 5 capsules | — | — | FDA listed | — |
| Temozolomide 140 mg 16571-0819-02 | Rising | 20 capsules | — | AB | FDA listed | — |
| Temozolomide 140 mg 72162-2662-02 | Bryant | 5 capsules | — | AB | FDA listed | — |
| Temozolomide 140 mg 82249-0410-05 | CivicaScript | 5 capsules | — | AB | FDA listed | — |
| temozolomide 140 mgthis 68382-0754-67 | Zydus | 14 capsules | — | AB | Discontinued | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Temozolomide inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Zydus Pharmaceuticals USA Inc. labeler code 68382
- Tiadylt ER diltiazem hydrochloride 120 mg Capsule, Extended Release NDC 68382-745-01
- Tiadylt ER diltiazem hydrochloride 180 mg Capsule, Extended Release NDC 68382-746-01
- Tiadylt ER diltiazem hydrochloride 240 mg Capsule, Extended Release NDC 68382-747-01
- Tiadylt ER diltiazem hydrochloride 300 mg Capsule, Extended Release NDC 68382-748-01
- Tiadylt ER diltiazem hydrochloride 360 mg Capsule, Extended Release NDC 68382-749-01
- Tiadylt ER diltiazem hydrochloride 420 mg Capsule, Extended Release NDC 68382-750-01
- Metformin Hydrochloride 500 mg Tablet, Film Coated NDC 68382-758-01
- Metformin Hydrochloride 850 mg Tablet, Film Coated NDC 68382-759-01
- Metformin Hydrochloride 1000 mg Tablet, Film Coated NDC 68382-760-01
- Topiramate 100 mg Capsule, Extended Release NDC 68382-769-01
- Lansoprazole 15 mg Tablet, Orally Disintegrating NDC 68382-771-77
- Lansoprazole 30 mg Tablet, Orally Disintegrating NDC 68382-772-77
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full prescribing information FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Medicare Part D spend CMS · PART D · 2025 (Q1-Q4)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA. |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | ✓ Available |
| HCPCS J-code billing crosswalk | ✓ Available |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |